Case Reports in Medicine

Case Reports in Medicine / 2013 / Article

Case Report | Open Access

Volume 2013 |Article ID 595193 | https://doi.org/10.1155/2013/595193

Pei-Yu Wu, Sheng-Fung Lin, Ping-Hsun Wu, Yi-Chun Tsai, Yu-Ting Kuo, Mei-Chuan Kuo, Hung-Chun Chen, "Multiple Hypovascular Tumors in Kidney: A Rare Case Report and Differential Diagnosis", Case Reports in Medicine, vol. 2013, Article ID 595193, 4 pages, 2013. https://doi.org/10.1155/2013/595193

Multiple Hypovascular Tumors in Kidney: A Rare Case Report and Differential Diagnosis

Academic Editor: Ahmet Tefekli
Received28 Aug 2013
Accepted20 Oct 2013
Published03 Dec 2013

Abstract

The most common malignant renal tumor is renal cell carcinoma and surgery is the standard treatment. The proportion of lymphoma with renal involvement is 2~15% and lymphoma could be cured by chemotherapy without nephrectomy. Sonography, computed tomography (CT), and magnetic resonance imaging (MRI) can detect and characterize a renal mass. We present a case of right renal hypovascular tumors and differential diagnosis of hypovascular tumors by image study. CT scan showed hypovascular tumors and MRI image revealed multifocal hypovascular solid tumors with significantly increased apparent diffusion coefficient (ADC) of diffusion weighted imaging (DWI). Based on image finding, renal lymphoma was highly suspected. Renal lymphoma was confirmed by renal biopsy and this patient received chemotherapy without surgery. The noninvasive CT scan and MRI image can help clinicians to diagnose the characteristics of renal mass and to avoid unnecessary nephrectomy.

1. Introduction

The most common incidental renal malignant tumor is renal cell carcinoma and renal lymphoma is rare. Sonography, computed tomography (CT), and magnetic resonance imaging (MRI) can detect and characterize a renal mass. The accurate diagnosis of a renal mass depends on many factors, including the clinical history, physical examination, image study, and sometimes renal biopsy may be considered. Thus, we present a case of right renal hypovascular tumors, which was confirmed as renal lymphoma by renal biopsy. Further differential diagnosis of a hypovascular tumor from image study was also discussed in this paper.

2. Case Presentation

A 52-year-old female had experienced intermittent epigastralgia with hunger pain and right flank pain without radiation for three months. Urine routine revealed microscopic hematuria with RBC count of 3–5 in high power field. Normocytic anemia with hemoglobin level of 11.3 g/dL without leukopenia or thrombocytopenia was shown. Neither abnormal coagulopathy nor liver and renal dysfunction were found. Abdominal sonography demonstrated a right hypo-echogenic renal mass at right upper and lower pole without hydronephrosis or kidney enlargement. Furthermore, abdominal CT showed multiple hypovascular tumors at the upper and lower pole and middle portions of the right kidney with sizes 3.3 cm, 2.5 cm, and 2.8 cm, respectively, without metastatic lymphadenopathy (Figure 1). Abdominal MRI revealed multifocal hypovascular solid tumors with significantly increased apparent diffusion coefficient (ADC) of diffusion weighted imaging (DWI) with enhancement during arterial phase of dynamic study and left renal hilar lymphadenopathy (Figure 2). Based on the imaging findings, CT-guide renal biopsy was performed. Renal pathology revealed renal cortex replaced by medium-sized to large atypical lymphoid cells and tumor cells, which are positive for Leucocyte Common Antigen (LCA), CD20, and CD10 immunohistochemical stain (Figure 3). Diffuse large B cell lymphoma was the confirmed diagnosis and Positron Emission tomography-computed tomography (PET/CT) showed the involvement in right kidney and stomach, compatible with diffuse large B cell lymphoma (stage IV). Normocellular bone marrow and normal chromosome were found by bone marrow biopsy. The patient received 6 cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab chemotherapy. However, the patient expired because of severe infection.

3. Discussion

The most common malignant renal tumor is renal cell carcinoma (80~85%) and transitional cell carcinoma (approximately 8%). Traditionally, renal biopsy has been indicated for evaluation of significant proteinuria, hematuria, or associated renal disease. Renal biopsy is usually not suggested for diagnosis of renal cell carcinoma because of the risk of tumor seeding from biopsy tract [1]. On the other hand, renal involvement in lymphoma is noted about 2~15% cases in CT scan finding which shows hypovascular characteristics [2, 3]. Conversely, renal biopsy has been regarded as the diagnostic tool of hypovascular renal tumor to avoid unnecessary nephrectomy regardless of primary or secondary lymphoma [4]. Thus, differential diagnosis of renal tumor in image study is important, especially renal lymphoma. Renal lymphoma may represent as single or multiple sonolucent or weakly echogenic masses on ultrasound [5]. However, this finding is nonspecific and not enough to confirm the diagnosis. Typical CT patterns of renal lymphoma include single or multiple masses, invasion from contiguous retroperitoneal disease, perirenal disease, and diffuse renal infiltration [6, 7]. In enhanced CT scan, renal lymphoma usually represents nonenhancement hypovascular tumor [8]. On the contrary, most clear cell renal cell carcinoma usually shows the enhancement [9], and only 15.9% displays the hypovascular or avascular tumor [10]. It is difficult to differentiate lymphoma in CT imaging. In this case, enhanced CT scan showed hypovascular tumors, which is not the typical CT finding of renal cell carcinoma, but hypovascular renal cell carcinoma cannot be excluded. Hence, further MRI study is needed and renal lymphoma usually shows isointense or slight hypointense masses on T1-weighted images and definite hypointense masses on T2-weighted images as compared with the signal intensity of the renal cortex [11]. DWI, a type of MRI image, allows visualization and measurement of the random (Brownian) extracellular and intracellular motion of water molecules driven by their internal thermal energy, and it is higher signal in high cell density lesion. Apparent diffusion coefficient (ADC) is a quantitative analysis from diffuse weight imaging. Lymphoma, known as high cell density tumor due to the feature of cell proliferation, shows a bright in DWI. In this case, MRI image showed multifocal hypovascular solid tumors of the right kidneys with high DWI signal intensity, which favors lymphoma infiltration than hypovascular renal cell carcinoma.

Based on of the results of ultrasound, CT scan, MRI image, and renal pathology, the diagnosis of lymphoma was confirmed. Beyond the pathology diagnosis, 18F-fluorodeoxyglucose (18F-FDG) PET/CT is helpful to diagnose lymphoma. Previous study indicated the higher 18F-FDG uptake in lymphoma lesions (SUV mean ) than renal clear cell carcinoma (SUV mean ), but similar to that of renal cell carcinoma and renal collecting duct carcinoma [12]. Hence, PET/CT is a useful tool in comparing lymphoma with other renal carcinoma [12] and is regarded as the most important advance of noninvasive assessment of lymphoma [13].

4. Conclusion

We conduct a process to use image tool for differential diagnosis etiology of a renal mass (Figure 4). The noninvasive CT scan and MRI can help clinicians to diagnose the characteristics of renal mass and to avoid unnecessary nephrectomy. Additionally, renal biopsy is indicated for evaluation of hypovascular renal tumor. Using adequate image study and renal biopsy could help clinicians to diagnose and treat hypovascular renal tumor.

References

  1. J. K. Mullins and R. Rodriguez, “Renal cell carcinoma seeding of a percutaneous biopsy tract,” Canadian Urological Association Journal, vol. 7, pp. E176–E179, 2013. View at: Google Scholar
  2. D. Villa, J. M. Connors, L. H. Sehn, R. D. Gascoyne, and K. J. Savage, “Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse,” Haematologica, vol. 96, no. 7, pp. 1002–1007, 2011. View at: Publisher Site | Google Scholar
  3. M. S. El-Sharkawy, N. Siddiqui, A. Aleem, and A. Al Diab, “Renal involvement in lymphoma: prevalence and various patterns of involvement on abdominal CT,” International Urology and Nephrology, vol. 39, no. 3, pp. 929–933, 2007. View at: Publisher Site | Google Scholar
  4. L. D. Truong, N. Caraway, T. Ngo, R. Laucirica, R. Katz, and I. Ramzy, “Renal lymphoma: the diagnostic and therapeutic roles of fine-needle aspiration,” American Journal of Clinical Pathology, vol. 115, no. 1, pp. 18–31, 2001. View at: Publisher Site | Google Scholar
  5. A. Shirkhoda, E. V. Stabb, and C. A. Mittelstaedt, “Renal lymphoma imaged by ultrasound and gallium-67,” Radiology, vol. 137, no. 1 I, pp. 175–180, 1980. View at: Google Scholar
  6. R. H. Cohan, N. R. Dunnick, R. A. Leder, and M. E. Baker, “Computed tomography of renal lymphoma,” Journal of Computer Assisted Tomography, vol. 14, no. 6, pp. 933–938, 1990. View at: Google Scholar
  7. B. A. Urban and E. K. Fishman, “Renal lymphoma: CT patterns with emphasis on helical CT,” Radiographics, vol. 20, pp. 197–212, 2000. View at: Google Scholar
  8. P. J. Eisenberg, N. Papanicolaou, M. J. Lee, and I. C. Yoder, “Diagnostic imaging in the evaluation of renal lymphoma,” Leukemia and Lymphoma, vol. 16, no. 1-2, pp. 37–50, 1994. View at: Google Scholar
  9. J. R. Young, D. Margolis, S. Sauk, A. J. Pantuck, J. Sayre, and S. S. Raman, “Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT,” Radiology, vol. 267, no. 2, pp. 444–453, 2013. View at: Google Scholar
  10. T. Onishi, Y. Oishi, H. Goto, S. Yanada, and K. Abe, “Histological features of hypovascular or avascular renal cell carcinoma: the experience at four university hospitals,” International Journal of Clinical Oncology, vol. 7, no. 3, pp. 159–164, 2002. View at: Publisher Site | Google Scholar
  11. Y. Imai, S. Sone, S. Serizawa et al., “Magnetic resonance imaging of renal lymphoma with computed tomography correlation,” Nippon Acta Radiologica, vol. 55, no. 8, pp. 562–568, 1995. View at: Google Scholar
  12. X. H. Ye, L. H. Chen, H. B. Wu et al., “18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma,” Southern Medical Journal, vol. 103, pp. 642–649, 2010. View at: Publisher Site | Google Scholar
  13. P. Seam, M. E. Juweid, and B. D. Cheson, “The role of FDG-PET scans in patients with lymphoma,” Blood, vol. 110, no. 10, pp. 3507–3516, 2007. View at: Publisher Site | Google Scholar

Copyright © 2013 Pei-Yu Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1809 Views | 788 Downloads | 0 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.